Amsterdam UMC, University of Amsterdam, Department of Experimental Immunology, Amsterdam Infection & Immunity Institute (AI&II), Cancer Center Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.
Amsterdam UMC, University of Amsterdam, Department of Experimental Immunology, Amsterdam Infection & Immunity Institute (AI&II), Cancer Center Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.
Curr Opin Immunol. 2021 Feb;68:28-33. doi: 10.1016/j.coi.2020.08.007. Epub 2020 Sep 21.
Five subsets of ILCs are extensively described, Lymphoid Tissue inducer (LTi) cells, cytotoxic NK cells and non-cytotoxic helper ILC1s, ILC2s and ILC3s. So far, the main focus has been on the potent cytokine production by helper ILCs and their plastic nature that allows them to switch function and phenotype upon environmental changes. Recent advances in the field indicate the presence of cytotoxic helper ILCs that are distinct from conventional NK cells. In humans, these cytotoxic ILCs can develop from conventional helper ILCs whereas in mice this remains to be elucidated. In this review we discuss the identification, development and function of cytotoxic helper ILCs subsets in humans and mice.
目前已广泛描述了五种 ILC 亚群,包括淋巴组织诱导(LTi)细胞、细胞毒性 NK 细胞和非细胞毒性辅助 ILC1、ILC2 和 ILC3。迄今为止,主要研究重点一直集中在辅助 ILC 产生强效细胞因子及其可塑性上,这使它们能够根据环境变化切换功能和表型。该领域的最新进展表明存在细胞毒性辅助 ILC,它们与传统 NK 细胞不同。在人类中,这些细胞毒性 ILC 可以从常规辅助 ILC 中发育而来,而在小鼠中这一点仍有待阐明。在本文中,我们讨论了细胞毒性辅助 ILC 亚群在人类和小鼠中的鉴定、发育和功能。